SERPINB1 and gestational diabetes: SERPINB1, a serine protease inhibitor involved in neutrophil function and inflammation, is indicative of increased GDM risk, with a sensitivity of 75.86%, specificity of 81.67%, and an AUC of 0.832 [79].